Persistence of Eosinophilic Asthma Endotype and Clinical Outcomes: A Real-World Observational Study

References

• Agache I, Beltran J, Akdis C, et al. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma. Allergy. 2020;75(5):1023–1042. doi:10.1111/all.14221
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention; 2020. Available from: www.ginasthma.org. Accessed November 2, 2020.
   Google Scholar
• Lee LK, Ramakrishnan K, Safioti G, Ariely R, Schatz M. Asthma control is associated with economic outcomes, work productivity and health-related quality of life in patients with asthma. BMJ Open Respir Res. 2020;7(1):e000534. doi:10.1136/bmjresp-2019-000534
   PubMed Web of Science ®Google Scholar
• Castillo JR, Peters SP, Busse WW. Asthma exacerbations: pathogenesis, prevention, and treatment. J Allergy Clin Immunol Pract. 2017;5(4):918–927. doi:10.1016/j.jaip.2017.05.001
   PubMed Web of Science ®Google Scholar
• Sundh J, Wireklint P, Hasselgren M, et al. Health-related quality of life in asthma patients - a comparison of two cohorts from 2005 and 2015. Respir Med. 2017;132:154–160. doi:10.1016/j.rmed.2017.10.010
   PubMed Web of Science ®Google Scholar
• Price DB, Trudo F, Voorham J, et al. Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. J Asthma Allergy. 2018;11:193–204. doi:10.2147/JAA.S176026
   PubMed Web of Science ®Google Scholar
• Voorham J, Xu X, Price DB, et al. Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma. Allergy. 2019;74(2):273–283. doi:10.1111/all.13556
   PubMed Web of Science ®Google Scholar
• Bateman ED, Buhl R, O’Byrne PM, et al. Development and validation of a novel risk score for asthma exacerbations: the risk score for exacerbations. J Allergy Clin Immunol. 2015;135(6):1457–1464 e1454. doi:10.1016/j.jaci.2014.08.015
   PubMed Web of Science ®Google Scholar
• Yii ACA, Tan JHY, Lapperre TS, et al. Long-term future risk of severe exacerbations: distinct 5-year trajectories of problematic asthma. Allergy. 2017;72(9):1398–1405. doi:10.1111/all.13159
   Web of Science ®Google Scholar
• DiMango E, Rogers L, Reibman J, et al. Risk factors for asthma exacerbation and treatment failure in adults and adolescents with well-controlled asthma during continuation and step-down therapy. Ann Am Thorac Soc. 2018;15(8):955–961. doi:10.1513/AnnalsATS.201711-886OC
   PubMed Web of Science ®Google Scholar
• Kuruvilla ME, Lee FE, Lee GB. Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clin Rev Allergy Immunol. 2019;56(2):219–233. doi:10.1007/s12016-018-8712-1
   PubMed Web of Science ®Google Scholar
• Nelson RK, Bush A, Stokes J, Nair P, Akuthota P. Eosinophilic asthma. J Allergy Clin Immunol Pract. 2020;8(2):465–473. doi:10.1016/j.jaip.2019.11.024
   PubMed Web of Science ®Google Scholar
• Tran TN, Khatry DB, Ke X, Ward CK, Gossage D. High blood eosinophil count is associated with more frequent asthma attacks in asthma patients. Ann Allergy Asthma Immunol. 2014;113(1):19–24. doi:10.1016/j.anai.2014.04.011
   Web of Science ®Google Scholar
• Zeiger RS, Schatz M, Li Q, et al. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma. J Allergy Clin Immunol Pract. 2014;2(6):741–750. doi:10.1016/j.jaip.2014.06.005
   PubMed Web of Science ®Google Scholar
• Price DB, Rigazio A, Campbell JD, et al. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study. Lancet Respir Med. 2015;3(11):849–858. doi:10.1016/S2213-2600(15)00367-7
   PubMed Web of Science ®Google Scholar
• Zeiger RS, Schatz M, Li Q, et al. The association of blood eosinophil counts to future asthma exacerbations in children with persistent asthma. J Allergy Clin Immunol Pract. 2015;3(2):283–287 e284. doi:10.1016/j.jaip.2014.10.009
   Web of Science ®Google Scholar
• Price D, Wilson AM, Chisholm A, et al. Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice. J Asthma Allergy. 2016;9:1–12. doi:10.2147/JAA.S97973
   PubMed Web of Science ®Google Scholar
• Zeiger RS, Schatz M, Dalal AA, et al. Blood eosinophil count and outcomes in severe uncontrolled asthma: a prospective study. J Allergy Clin Immunol Pract. 2017;5(1):144–153 e148. doi:10.1016/j.jaip.2016.07.015
   PubMed Web of Science ®Google Scholar
• Kerkhof M, Tran TN, van den Berge M, et al. Association between blood eosinophil count and risk of readmission for patients with asthma: historical cohort study. PLoS One. 2018;13(7):e0201143. doi:10.1371/journal.pone.0201143
   PubMed Web of Science ®Google Scholar
• Suruki RY, Daugherty JB, Boudiaf N, Albers FC. The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA. BMC Pulm Med. 2017;17(1):74. doi:10.1186/s12890-017-0409-3
   PubMed Web of Science ®Google Scholar
• Kerkhof M, Tran TN, Soriano JB, et al. Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population. Thorax. 2018;73(2):116–124. doi:10.1136/thoraxjnl-2017-210531
   PubMed Web of Science ®Google Scholar
• Fleming L, Tsartsali L, Wilson N, Regamey N, Bush A. Sputum inflammatory phenotypes are not stable in children with asthma. Thorax. 2012;67(8):675–681. doi:10.1136/thoraxjnl-2011-201064
   PubMed Web of Science ®Google Scholar
• Spector SL, Tan RA. Is a single blood eosinophil count a reliable marker for “eosinophilic asthma?”. J Asthma. 2012;49(8):807–810. doi:10.3109/02770903.2012.713428
   PubMed Web of Science ®Google Scholar
• Kupczyk M, Dahlen B, Sterk PJ, et al. Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma. Allergy. 2014;69(9):1198–1204. doi:10.1111/all.12445
   PubMed Web of Science ®Google Scholar
• Mathur SK, Fichtinger PS, Evans MD, Schwantes EA, Jarjour NN. Variability of blood eosinophil count as an asthma biomarker. Ann Allergy Asthma Immunol. 2016;117(5):551–553. doi:10.1016/j.anai.2016.08.010
   Web of Science ®Google Scholar
• Silkoff PE, Laviolette M, Singh D, et al. Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study. Respir Res. 2016;17(1):43. doi:10.1186/s12931-016-0360-5
   Web of Science ®Google Scholar
• Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015;44(3):827–836. doi:10.1093/ije/dyv098
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention; 2018. Available from: www.ginasthma.org. Accessed November 9, 2020.
   Google Scholar
• Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention; 2019. Available from: www.ginasthma.org. Accessed November 9, 2020.
   Google Scholar
• Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180(1):59–99. doi:10.1164/rccm.200801-060ST
   PubMed Web of Science ®Google Scholar
• Steven K, Neville RG, Hoskins G, Sullivan FM, Drummond N, Alder EM. The RCP’s ‘Three Key Questions’ for asthma: review of practical use. Br J Community Nurs. 2002;7(6):300–303. doi:10.12968/bjcn.2002.7.6.10474
   Google Scholar
• Colice G, Chisholm A, Dima AL, et al. Performance of database-derived severe exacerbations and asthma control measures in asthma: responsiveness and predictive utility in a UK primary care database with linked questionnaire data. Pragmat Obs Res. 2018;9:29–42. doi:10.2147/POR.S151615
   PubMed Web of Science ®Google Scholar
• Faraone SV. Interpreting estimates of treatment effects: implications for managed care. P T. 2008;33(12):700–711.
   PubMedGoogle Scholar
• Ricciardolo FLM, Levra S, Sprio AE, et al. A real-world assessment of asthma with chronic rhinosinusitis. Ann Allergy Asthma Immunol. 2020;125(1):65–71. doi:10.1016/j.anai.2020.03.004
   Web of Science ®Google Scholar
• Volmer T, Effenberger T, Trautner C, Buhl R. Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature. Eur Respir J. 2018;52(4):1800703. doi:10.1183/13993003.00703-2018
   PubMed Web of Science ®Google Scholar
• Pavord ID, Mathieson N, Scowcroft A, Pedersini R, Isherwood G, Price D. The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting beta2-agonists in the United Kingdom: a cross-sectional analysis. NPJ Prim Care Respir Med. 2017;27(1):17. doi:10.1038/s41533-017-0014-1
   PubMed Web of Science ®Google Scholar
• Blakey JD, Gayle A, Slater MG, Jones GH, Baldwin M. Observational cohort study to investigate the unmet need and time waiting for referral for specialist opinion in adult asthma in England (UNTWIST asthma). BMJ Open. 2019;9(11):e031740. doi:10.1136/bmjopen-2019-031740
   PubMed Web of Science ®Google Scholar
• Mahdavian M, Power BH, Asghari S, Pike JC. Effects of comorbidities on asthma hospitalization and mortality rates: a systematic review. Can Respir J. 2018;2018:6460379. doi:10.1155/2018/6460379
   PubMed Web of Science ®Google Scholar
• Durrington HJ, Gioan-Tavernier GO, Maidstone RJ, et al. Time of day affects eosinophil biomarkers in asthma: implications for diagnosis and treatment. Am J Respir Crit Care Med. 2018;198(12):1578–1581. doi:10.1164/rccm.201807-1289LE
   PubMed Web of Science ®Google Scholar
• Coates S, Wang D, Pierscionek T, et al. Time- and race-specific haematological reference intervals for healthy volunteer trials: a retrospective analysis of pooled data from multiple Phase I trials. Front Pharmacol. 2020;11:314. doi:10.3389/fphar.2020.00314
   PubMed Web of Science ®Google Scholar